Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections [PDF]
Drug Design, Development and Therapy, 2016 Olivia Ferrández,1,2 Olatz Urbina,1 Santiago Grau1,3 1Hospital Pharmacy, Hospital Universitari del Mar, Barcelona, Spain; 2Nursing Department, Universitat Pompeu Fabra, Barcelona, Spain; 3Medicine Department, Universitat Autònoma de ...
Ferrández O, Urbina O, Grau S
doaj +8 more sources
Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience [PDF]
AntibioticsAcute Bacterial Skin and Skin Structure Infections (ABSSSI) are marked by substantial morbidity, frequent need for hospitalization, and long courses of intravenous antibiotic therapy. Herein, we report four cases of pediatric patients admitted for ABSSSI
Sara Maria Scarano +5 more
doaj +4 more sources
Tackling Extended Hospital Stays in Patients with Acute Bacterial Skin and Skin Structure Infections [PDF]
European Medical Journal, 2022 Hospitalisation rates for acute bacterial skin and skin structure infection (ABSSSI) are rising and represent a large pharmacoeconomic burden as treatment may involve an extended number of days of antibiotic therapy. This article first aims to provide a
Gavin Barlow +2 more
doaj +2 more sources
The efficacy and adverse events of delafloxacin for treating acute bacterial skin and skin structure infections: A systematic review and meta-analysis [PDF]
Journal of Pharmacy and Bioallied Sciences, 2020 Background: Acute bacterial skin and skin structure infections (ABSSSI) cause significant morbidity and mortality in hospitalized patients and outpatients as well.
Syed Bilal Tanvir +4 more
doaj +4 more sources
The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) [PDF]
Expert Review of Anti-infective Therapy, 2020 Introduction: Acute bacterial skin and skin-structure infections (ABSSSI) are a subgroup of skin and soft tissue infections and are a common source of morbidity in both the community and the hospital setting. The most common cause of ABSSSI is Staphylococcus aureus, which also includes methicillin-resistant S.
Alex Soriano +2 more
openaire +6 more sources
Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections [PDF]
Global & Regional Health Technology AssessmentIntroduction: Inpatient treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) involves a significant economic burden on the healthcare system.
Matteo Scortichini +4 more
doaj +2 more sources
Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections. [PDF]
J Pharm Technol, 2019 Objective: To review the microbiological activity, safety, and efficacy of the new fluoroquinolone delafloxacin for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Data Sources: A PubMed search from 1945 to September 2018 was done using the terms delafloxacin, acute bacterial skin and skin structure infections, skin and ...
Lee YR, Burton CE, Bevel KR.
europepmc +4 more sources
Journal of Global Antimicrobial Resistance, 2020 Objectives: The aim of this survey was to identify a set of actions aimed to improve the diagnosis and management of acute bacterial skin and skin-structure infections (ABSSSIs) and the implementation of some principles of antimicrobial stewardship (AMS)
Alex Soriano +3 more
doaj +3 more sources
Opportunities for antimicrobial stewardship in patients with acute bacterial skin and skin structure infections who are unsuitable for beta-lactam antibiotics: a multicenter prospective observational study [PDF]
Therapeutic Advances in Infectious Disease, 2019 Purpose: The objective of this prospective, observational study was to describe the treatment, severity assessment and healthcare resources required for management of patients with acute bacterial skin and skin structure infections who were unsuitable ...
Jonathan A.T. Sandoe +8 more
doaj +2 more sources
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin [PDF]
Infection and Drug Resistance, 2018 Elda Righi, Alessia Carnelutti, Antonio Vena, Matteo Bassetti Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy Abstract: The increase in hospitalization due to acute bacterial skin and skin ...
Righi E +3 more
doaj +2 more sources